Inactive Instrument

EXMceuticals Inc.

EXM

CA30207T1049

Exmceuticals Inc. Reports Earnings Results for the Full Year Ended June 30, 2019

December 05, 2019 at 02:01 pm EST

EXMceuticals Inc. announced earnings results for the full year ended June 30, 2019. For the full year, the company announced net loss was CAD 9.689 million compared to CAD 1.324 million a year ago. Basic loss per share was CAD 0.43 compared to CAD 0.49 a year ago.

Latest news about EXMceuticals Inc.

An unknown buyer acquired EXMceuticals Portugal Lda from EXMceuticals Inc. for €0.08 million.	22-04-04	CI
Global Cannabinoids Inc. cancelled the acquisition of EXMceuticals Inc..	22-01-09	CI
EXMceuticals Inc. Announces CEO Changes	21-12-22	CI
EXMceuticals Inc. Announces Resignation of Board Members	21-06-30	CI
Exmceuticals Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-31	CI
Global Cannabinoids and EXMceuticals Inc. Announce Management Appointments for the Combined Coampny	21-03-03	CI
EXMceuticals Inc. announced that it expects to receive CAD 6 million in funding	21-03-02	CI
Global Cannabinoids entered into an exclusive non-binding letter of intent to acquire EXMceuticals Inc. in a reverse merger transaction for CAD 33.6 million.	21-03-02	CI
EXMceuticals Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	21-01-27	CI
An unknown buyer signed an agreement to acquire 70% stake in Prime Ranchers Limited from EXMceuticals Inc. for $0.15 million.	20-12-28	CI
EXMceuticals Inc. Auditor Raises 'Going Concern' Doubt	20-12-28	CI
Exmceuticals Inc. Announces Receipt of COVID-19 Research Grant and Acceleration of Portuguese Activities	20-09-08	CI
EXMceuticals Inc. announced that it has received $0.030467 million in funding	20-08-30	CI
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight Covid-19 Pandemic	20-08-25	CI
EXMceuticals Inc. announced that it expects to receive $0.030467 million in funding	20-08-19	CI
EXMceuticals Inc. announced that it has received $0.100702 million in funding	20-08-18	CI
EXMceuticals Inc. announced that it expects to receive $0.100702 million in funding	20-08-05	CI
EXMceuticals Inc. announced that it has received CAD 1.036 million in funding	20-07-21	CI
Exmceuticals Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-07-03	CI
EXMceuticals Inc. cancelled the acquisition of MM Ltd.	20-06-29	CI
EXMceuticals Inc. Announces Supply Agreement for THC Distillate	20-06-11	CI
Exmceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery	20-05-07	CI
EXMceuticals Inc. Announces First Closing of Loan Agreement	20-03-25	CI
EXMceuticals Inc. Announces Directorship Changes	20-03-03	CI
Exmceuticals Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-03-02	CI

Chart EXMceuticals Inc.

Duration

Period

More charts

Company Profile

EXMceuticals Inc. is a bio-sciences company that is focused on the production of cannabinoid formulations. The Company operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company's subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.

Sector

Pharmaceuticals

More about the company